Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Revenue	9	9.51	16.98	19.4	20.12
Revenue Growth (YoY)	-5.34%	-43.99%	-12.48%	-3.56%	-6.72%
Cost of Revenue	6.09	6.99	11.91	14.52	14.76
Gross Profit	2.91	2.52	5.07	4.88	5.36
Selling, General & Admin	3.55	3.8	3.95	3.71	4.01
Operating Expenses	3.55	3.8	3.95	3.71	9.21
Operating Income	-0.64	-1.29	1.12	1.17	-3.85
Interest & Investment Income	0.64	0.53	-	-	-
Currency Exchange Gain (Loss)	-0.1	-	-	-	-
Other Non Operating Income (Expenses)	-	-	0.57	0.01	0.02
EBT Excluding Unusual Items	-0.09	-0.76	1.69	1.19	-3.83
Other Unusual Items	-	-	-	-	1.96
Pretax Income	-0.09	-0.76	1.69	1.19	-1.88
Income Tax Expense	0.01	0.02	0.38	0.18	0.21
Earnings From Continuing Operations	-0.1	-0.78	1.31	1.01	-2.09
Net Income	-0.1	-0.78	1.31	1.01	-2.09
Net Income to Common	-0.1	-0.78	1.31	1.01	-2.09
Net Income Growth	-	-	30.15%	-	-
Shares Outstanding (Basic)	23	23	23	23	23
Shares Outstanding (Diluted)	23	23	23	23	23
Shares Change (YoY)	-0.07%	-0.10%	-0.15%	-0.56%	0.53%
EPS (Basic)	-0.00	-0.03	0.06	0.04	-0.09
EPS (Diluted)	-0.00	-0.03	0.06	0.04	-0.09
EPS Growth	-	-	30.25%	-	-
Free Cash Flow	-0.22	-0.73	1.88	0.57	0.79
Free Cash Flow Per Share	-0.01	-0.03	0.08	0.03	0.03
Gross Margin	32.33%	26.46%	29.84%	25.16%	26.65%
Operating Margin	-7.08%	-13.54%	6.58%	6.06%	-19.16%
Profit Margin	-1.12%	-8.18%	7.72%	5.19%	-10.39%
Free Cash Flow Margin	-2.46%	-7.64%	11.10%	2.96%	3.95%
EBITDA	-0.58	-1.26	1.17	1.23	-3.78
EBITDA Margin	-6.42%	-13.30%	6.87%	6.32%	-18.80%
D&A For EBITDA	0.06	0.02	0.05	0.05	0.07
EBIT	-0.64	-1.29	1.12	1.17	-3.85
EBIT Margin	-7.08%	-13.54%	6.58%	6.06%	-19.16%
Effective Tax Rate	-	-	22.36%	15.29%	-

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.